107 related articles for article (PubMed ID: 19035282)
1. Molecular mechanisms and gene regulation of melphalan- and hyperthermia-induced apoptosis in Ewing sarcoma cells.
Krause C; Klüttermann K; Mauz-Körholz C
Anticancer Res; 2008; 28(5A):2585-93. PubMed ID: 19035282
[TBL] [Abstract][Full Text] [Related]
2. TRAIL-induced cytotoxicity in a melphalan-resistant rhabdomyosarcoma cell line via activation of caspase-2.
Klüttermann K; Banning U; Kachel M; Krause C; Körholz D; Mauz-Körholz C
Anticancer Res; 2006; 26(1A):351-6. PubMed ID: 16475717
[TBL] [Abstract][Full Text] [Related]
3. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC
Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of human Ewing's tumor cells to chemotherapy and heat treatment by the bioflavonoid quercetin.
Debes A; Oerding M; Willers R; Göbel U; Wessalowski R
Anticancer Res; 2003; 23(4):3359-66. PubMed ID: 12926076
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced caspase-3 activation in a Ewing tumor cell line and primary Ewing tumor cells.
Mauz-Körholz C; Kachel M; Harms-Schirra B; Klein-Vehne A; Tunn PU; Körholz D
Anticancer Res; 2004; 24(1):145-9. PubMed ID: 15015589
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of hyperthermia- and cisplatin-induced cytotoxicity in T cell leukemia.
Mauz-Körholz C; Dietzsch S; Schippel P; Banning U; Körholz D
Anticancer Res; 2003; 23(3B):2643-7. PubMed ID: 12894552
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of hyperthermia- and 4-hydroperoxy-ifosfamide-induced cytotoxicity in T cell leukemia.
Mauz-Körholz C; Dietzsch S; Banning U; Tröbs RB; Körholz D
Anticancer Res; 2002; 22(6C):4243-7. PubMed ID: 12553065
[TBL] [Abstract][Full Text] [Related]
8. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.
Hazlehurst LA; Enkemann SA; Beam CA; Argilagos RF; Painter J; Shain KH; Saporta S; Boulware D; Moscinski L; Alsina M; Dalton WS
Cancer Res; 2003 Nov; 63(22):7900-6. PubMed ID: 14633719
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway.
Casado-Zapico S; Rodriguez-Blanco J; García-Santos G; Martín V; Sánchez-Sánchez AM; Antolín I; Rodriguez C
J Pineal Res; 2010 Jan; 48(1):72-80. PubMed ID: 20025643
[TBL] [Abstract][Full Text] [Related]
10. c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells.
Lorin S; Borges A; Ribeiro Dos Santos L; Souquère S; Pierron G; Ryan KM; Codogno P; Djavaheri-Mergny M
Cancer Res; 2009 Sep; 69(17):6924-31. PubMed ID: 19706754
[TBL] [Abstract][Full Text] [Related]
11. The alkylating prodrug J1 can be activated by aminopeptidase N, leading to a possible target directed release of melphalan.
Wickström M; Viktorsson K; Lundholm L; Aesoy R; Nygren H; Sooman L; Fryknäs M; Vogel LK; Lewensohn R; Larsson R; Gullbo J
Biochem Pharmacol; 2010 May; 79(9):1281-90. PubMed ID: 20067771
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
Cillessen SA; Hess CJ; Hooijberg E; Castricum KC; Kortman P; Denkers F; Vos W; van de Wiel MA; Schuurhuis GJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
Clin Cancer Res; 2007 Dec; 13(23):7012-21. PubMed ID: 18056177
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
14. Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro.
Urano M; Ling CC
Int J Hyperthermia; 2002; 18(4):307-15. PubMed ID: 12079586
[TBL] [Abstract][Full Text] [Related]
15. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
[TBL] [Abstract][Full Text] [Related]
16. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
[TBL] [Abstract][Full Text] [Related]
17. Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy.
Schaefer KL; Eisenacher M; Braun Y; Brachwitz K; Wai DH; Dirksen U; Lanvers-Kaminsky C; Juergens H; Herrero D; Stegmaier S; Koscielniak E; Eggert A; Nathrath M; Gosheger G; Schneider DT; Bury C; Diallo-Danebrock R; Ottaviano L; Gabbert HE; Poremba C
Eur J Cancer; 2008 Mar; 44(5):699-709. PubMed ID: 18294840
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
Wu XX; Kakehi Y
Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
[TBL] [Abstract][Full Text] [Related]
19. Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumours.
Luksch R; Grignani G; Fagioli F; Brach del Prever A; Podda M; Aliberti S; Casanova M; Prete A; Hanau G; Tamburini A; Allione P; Tienghi A; Ferrari S; Collini P; Marchianò A; Gandola L; Aglietta M; Madon E; Picci P; Fossati-Bellani F
Eur J Cancer; 2007 Mar; 43(5):885-90. PubMed ID: 17254770
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP.
Lee JT; Lee TJ; Kim CH; Kim NS; Kwon TK
Cancer Lett; 2009 Jul; 279(2):185-92. PubMed ID: 19250737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
